Ovoca Bio's "Female Viagra" Nasal Spray Inching Closer to Market

Called “female Viagra” in the media, Ovoca Bio’s BP-101 (Libicore) nasal spray therapy for low libidos in premenopausal women is undergoing Phase II trials in Australia and New Zealand, and is being reviewed by the Russian Ministry of Health after successful Phase III trials in that country. A decision regarding approval in Russia is expected later this year.